Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Comparative analysis of viral entry for Asian and African lineages of Zika virus.

Rinkenberger N, Schoggins JW.

Virology. 2019 Apr 25;533:59-67. doi: 10.1016/j.virol.2019.04.008. [Epub ahead of print]

PMID:
31112915
2.

Shared and Distinct Functions of Type I and Type III Interferons.

Lazear HM, Schoggins JW, Diamond MS.

Immunity. 2019 Apr 16;50(4):907-923. doi: 10.1016/j.immuni.2019.03.025. Review.

PMID:
30995506
3.

A NIK-SIX signalling axis controls inflammation by targeted silencing of non-canonical NF-κB.

Liu Z, Mar KB, Hanners NW, Perelman SS, Kanchwala M, Xing C, Schoggins JW, Alto NM.

Nature. 2019 Apr;568(7751):249-253. doi: 10.1038/s41586-019-1041-6. Epub 2019 Mar 20.

PMID:
30894749
4.

A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.

Hubel P, Urban C, Bergant V, Schneider WM, Knauer B, Stukalov A, Scaturro P, Mann A, Brunotte L, Hoffmann HH, Schoggins JW, Schwemmle M, Mann M, Rice CM, Pichlmair A.

Nat Immunol. 2019 Apr;20(4):493-502. doi: 10.1038/s41590-019-0323-3. Epub 2019 Mar 4.

PMID:
30833792
5.

A CRISPR screen identifies IFI6 as an ER-resident interferon effector that blocks flavivirus replication.

Richardson RB, Ohlson MB, Eitson JL, Kumar A, McDougal MB, Boys IN, Mar KB, De La Cruz-Rivera PC, Douglas C, Konopka G, Xing C, Schoggins JW.

Nat Microbiol. 2018 Nov;3(11):1214-1223. doi: 10.1038/s41564-018-0244-1. Epub 2018 Sep 17.

6.

LY6E mediates an evolutionarily conserved enhancement of virus infection by targeting a late entry step.

Mar KB, Rinkenberger NR, Boys IN, Eitson JL, McDougal MB, Richardson RB, Schoggins JW.

Nat Commun. 2018 Sep 6;9(1):3603. doi: 10.1038/s41467-018-06000-y.

7.

Recent advances in antiviral interferon-stimulated gene biology.

Schoggins JW.

F1000Res. 2018 Mar 12;7:309. doi: 10.12688/f1000research.12450.1. eCollection 2018. Review.

8.

Mucolipin-2 Cation Channel Increases Trafficking Efficiency of Endocytosed Viruses.

Rinkenberger N, Schoggins JW.

MBio. 2018 Jan 30;9(1). pii: e02314-17. doi: 10.1128/mBio.02314-17.

9.

The IFN Response in Bats Displays Distinctive IFN-Stimulated Gene Expression Kinetics with Atypical RNASEL Induction.

De La Cruz-Rivera PC, Kanchwala M, Liang H, Kumar A, Wang LF, Xing C, Schoggins JW.

J Immunol. 2018 Jan 1;200(1):209-217. doi: 10.4049/jimmunol.1701214. Epub 2017 Nov 27.

10.

Genetic Variation at IFNL4 Influences Extrahepatic Interferon-Stimulated Gene Expression in Chronic HCV Patients.

Rosenberg BR, Freije CA, Imanaka N, Chen ST, Eitson JL, Caron R, Uhl SA, Zeremski M, Talal A, Jacobson IM, Rice CM, Schoggins JW.

J Infect Dis. 2018 Jan 30;217(4):650-655. doi: 10.1093/infdis/jix593.

11.

The cellular endosomal protein stannin inhibits intracellular trafficking of human papillomavirus during virus entry.

Lipovsky A, Erden A, Kanaya E, Zhang W, Crite M, Bradfield C, MacMicking J, DiMaio D, Schoggins JW, Iwasaki A.

J Gen Virol. 2017 Nov;98(11):2821-2836. doi: 10.1099/jgv.0.000954. Epub 2017 Oct 23.

12.

Cell-Based Screen Identifies Human Interferon-Stimulated Regulators of Listeria monocytogenes Infection.

Perelman SS, Abrams ME, Eitson JL, Chen D, Jimenez A, Mettlen M, Schoggins JW, Alto NM.

PLoS Pathog. 2016 Dec 21;12(12):e1006102. doi: 10.1371/journal.ppat.1006102. eCollection 2016 Dec.

13.

Western Zika Virus in Human Fetal Neural Progenitors Persists Long Term with Partial Cytopathic and Limited Immunogenic Effects.

Hanners NW, Eitson JL, Usui N, Richardson RB, Wexler EM, Konopka G, Schoggins JW.

Cell Rep. 2016 Jun 14;15(11):2315-22. doi: 10.1016/j.celrep.2016.05.075. Epub 2016 Jun 3.

14.

NLRX1 Helps HIV Avoid a STING Operation.

Mar KB, Schoggins JW.

Cell Host Microbe. 2016 Apr 13;19(4):430-1. doi: 10.1016/j.chom.2016.03.011.

15.

A phospholipase linkAGE to SARS susceptibility.

Schoggins JW.

J Exp Med. 2015 Oct 19;212(11):1755. doi: 10.1084/jem.21211insight2. No abstract available.

16.

IMMUNOLOGY. Viruses carry antiviral cargo.

Schoggins JW.

Science. 2015 Sep 11;349(6253):1166-7. doi: 10.1126/science.aad0942. No abstract available.

PMID:
26359389
17.

A Sense of Self: RIG-I's Tolerance to Host RNA.

Schoggins JW.

Immunity. 2015 Jul 21;43(1):1-2. doi: 10.1016/j.immuni.2015.06.022.

18.

Corrigendum: A diverse range of gene products are effectors of the type I interferon antiviral response.

Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, Rice CM.

Nature. 2015 Sep 3;525(7567):144. doi: 10.1038/nature14554. Epub 2015 Jul 8. No abstract available.

PMID:
26153858
19.

Corrigendum: Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity.

Schoggins JW, MacDuff DA, Imanaka N, Gainey MD, Shrestha B, Eitson JL, Mar KB, Richardson RB, Ratushny AV, Litvak V, Dabelic R, Manicassamy B, Aitchison JD, Aderem A, Elliott RM, García-Sastre A, Racaniello V, Snijder EJ, Yokoyama WM, Diamond MS, Virgin HW, Rice CM.

Nature. 2015 Sep 3;525(7567):144. doi: 10.1038/nature14555. Epub 2015 Jul 8. No abstract available.

PMID:
26153856
20.

Common variants associated with general and MMR vaccine-related febrile seizures.

Feenstra B, Pasternak B, Geller F, Carstensen L, Wang T, Huang F, Eitson JL, Hollegaard MV, Svanström H, Vestergaard M, Hougaard DM, Schoggins JW, Jan LY, Melbye M, Hviid A.

Nat Genet. 2014 Dec;46(12):1274-82. doi: 10.1038/ng.3129. Epub 2014 Oct 26.

21.

Interferon-stimulated genes: roles in viral pathogenesis.

Schoggins JW.

Curr Opin Virol. 2014 Jun;6:40-6. doi: 10.1016/j.coviro.2014.03.006. Epub 2014 Apr 5. Review.

22.

Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity.

Schoggins JW, MacDuff DA, Imanaka N, Gainey MD, Shrestha B, Eitson JL, Mar KB, Richardson RB, Ratushny AV, Litvak V, Dabelic R, Manicassamy B, Aitchison JD, Aderem A, Elliott RM, García-Sastre A, Racaniello V, Snijder EJ, Yokoyama WM, Diamond MS, Virgin HW, Rice CM.

Nature. 2014 Jan 30;505(7485):691-5. doi: 10.1038/nature12862. Epub 2013 Nov 27. Erratum in: Nature. 2015 Sep 3;525(7567):144.

23.

Lipids in innate antiviral defense.

Schoggins JW, Randall G.

Cell Host Microbe. 2013 Oct 16;14(4):379-85. doi: 10.1016/j.chom.2013.09.010. Review.

24.

MX2 is an interferon-induced inhibitor of HIV-1 infection.

Kane M, Yadav SS, Bitzegeio J, Kutluay SB, Zang T, Wilson SJ, Schoggins JW, Rice CM, Yamashita M, Hatziioannou T, Bieniasz PD.

Nature. 2013 Oct 24;502(7472):563-6. doi: 10.1038/nature12653. Epub 2013 Oct 13.

25.

IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage.

Cheon H, Holvey-Bates EG, Schoggins JW, Forster S, Hertzog P, Imanaka N, Rice CM, Jackson MW, Junk DJ, Stark GR.

EMBO J. 2013 Oct 16;32(20):2751-63. doi: 10.1038/emboj.2013.203. Epub 2013 Sep 24.

26.

Host restriction factor screening: let the virus do the work.

Diamond MS, Schoggins JW.

Cell Host Microbe. 2013 Sep 11;14(3):229-31. doi: 10.1016/j.chom.2013.08.014.

27.

Regulating interferon antiviral activity: a role for epidermal growth factor receptor.

Schoggins JW.

Hepatology. 2013 Oct;58(4):1200-2. doi: 10.1002/hep.26486. Epub 2013 Sep 12. No abstract available.

PMID:
23703779
28.

Innate immune responses to hepatitis C virus.

Schoggins JW, Rice CM.

Curr Top Microbiol Immunol. 2013;369:219-42. doi: 10.1007/978-3-642-27340-7_9. Review.

PMID:
23463203
29.

Inhibition of HIV-1 particle assembly by 2',3'-cyclic-nucleotide 3'-phosphodiesterase.

Wilson SJ, Schoggins JW, Zang T, Kutluay SB, Jouvenet N, Alim MA, Bitzegeio J, Rice CM, Bieniasz PD.

Cell Host Microbe. 2012 Oct 18;12(4):585-97. doi: 10.1016/j.chom.2012.08.012.

30.

Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro.

Schoggins JW, Dorner M, Feulner M, Imanaka N, Murphy MY, Ploss A, Rice CM.

Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14610-5. doi: 10.1073/pnas.1212379109. Epub 2012 Aug 20.

31.

Mycobacterial disease and impaired IFN-γ immunity in humans with inherited ISG15 deficiency.

Bogunovic D, Byun M, Durfee LA, Abhyankar A, Sanal O, Mansouri D, Salem S, Radovanovic I, Grant AV, Adimi P, Mansouri N, Okada S, Bryant VL, Kong XF, Kreins A, Velez MM, Boisson B, Khalilzadeh S, Ozcelik U, Darazam IA, Schoggins JW, Rice CM, Al-Muhsen S, Behr M, Vogt G, Puel A, Bustamante J, Gros P, Huibregtse JM, Abel L, Boisson-Dupuis S, Casanova JL.

Science. 2012 Sep 28;337(6102):1684-8. Epub 2012 Aug 2.

32.

Multiple interferon stimulated genes synergize with the zinc finger antiviral protein to mediate anti-alphavirus activity.

Karki S, Li MM, Schoggins JW, Tian S, Rice CM, MacDonald MR.

PLoS One. 2012;7(5):e37398. doi: 10.1371/journal.pone.0037398. Epub 2012 May 16.

33.

Interferon-stimulated genes and their antiviral effector functions.

Schoggins JW, Rice CM.

Curr Opin Virol. 2011 Dec;1(6):519-25. doi: 10.1016/j.coviro.2011.10.008. Review.

34.

Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells.

Andrus L, Marukian S, Jones CT, Catanese MT, Sheahan TP, Schoggins JW, Barry WT, Dustin LB, Trehan K, Ploss A, Bhatia SN, Rice CM.

Hepatology. 2011 Dec;54(6):1901-12. doi: 10.1002/hep.24557.

35.

A genetically humanized mouse model for hepatitis C virus infection.

Dorner M, Horwitz JA, Robbins JB, Barry WT, Feng Q, Mu K, Jones CT, Schoggins JW, Catanese MT, Burton DR, Law M, Rice CM, Ploss A.

Nature. 2011 Jun 8;474(7350):208-11. doi: 10.1038/nature10168.

36.

A diverse range of gene products are effectors of the type I interferon antiviral response.

Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, Rice CM.

Nature. 2011 Apr 28;472(7344):481-5. doi: 10.1038/nature09907. Epub 2011 Apr 10. Erratum in: Nature. 2015 Sep 3;525(7567):144.

37.

Splicing diversity of the human OCLN gene and its biological significance for hepatitis C virus entry.

Kohaar I, Ploss A, Korol E, Mu K, Schoggins JW, O'Brien TR, Rice CM, Prokunina-Olsson L.

J Virol. 2010 Jul;84(14):6987-94. doi: 10.1128/JVI.00196-10. Epub 2010 May 12.

38.

Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system.

Jones CT, Catanese MT, Law LM, Khetani SR, Syder AJ, Ploss A, Oh TS, Schoggins JW, MacDonald MR, Bhatia SN, Rice CM.

Nat Biotechnol. 2010 Feb;28(2):167-71. doi: 10.1038/nbt.1604. Epub 2010 Jan 31.

39.

Serotype 5 Adenovirus fiber (F7F41S) chimeric vectors incur packaging deficiencies when targeting peptides are inserted into Ad41 short fiber.

Schoggins JW, Falck-Pedersen E.

Virology. 2009 Dec 5;395(1):10-20. doi: 10.1016/j.virol.2009.08.041. Epub 2009 Sep 25.

40.
42.

Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation.

Schoggins JW, Nociari M, Philpott N, Falck-Pedersen E.

J Virol. 2005 Sep;79(18):11627-37.

43.
44.

Coordinate expression of secretory phospholipase A(2) and cyclooxygenase-2 in activated human keratinocytes.

Rys-Sikora KE, Konger RL, Schoggins JW, Malaviya R, Pentland AP.

Am J Physiol Cell Physiol. 2000 Apr;278(4):C822-33.

45.

Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition.

Pentland AP, Schoggins JW, Scott GA, Khan KN, Han R.

Carcinogenesis. 1999 Oct;20(10):1939-44.

PMID:
10506108

Supplemental Content

Loading ...
Support Center